Search Results - "Mayordomo, JI"

ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma by Gurzau, Eugene, Jakobsdottir, Margret, Magnusson, Veronica, Kumar, Rajiv, Olafsson, Jon H, Ragnarsson, Rafn, Kiemeney, Lambertus A, Thorisdottir, Kristin, Benediktsdottir, Kristrun R, Kostulas, Konstantinos, Botella-Estrada, Rafael, Gretarsdottir, Solveig, Hansson, Johan, Thorsteinsdottir, Unnur, Grasa, Matilde, Saez, Berta, Steinberg, Stacy, Rudnai, Peter, Stacey, Simon N, Gudbjartsson, Daniel F, Goldstein, Alisa M, Andres, Raquel, Mayordomo, José I, Gulcher, Jeffrey, Kong, Augustine, Sveinsdottir, Steinunn G, Sulem, Patrick, Stefansson, Kari, Rafnar, Thorunn, Koppova, Kvetoslava, Tucker, Margaret A, Juberías, Pablo, Lindblom, Annika, Nagore, Eduardo, Sigurgeirsson, Bardur, Scherer, Dominique, Soriano, Virtudes, Helgason, Agnar

“…Fair color increases risk of cutaneous melanoma (CM) and basal cell carcinoma (BCC). Recent genome-wide association studies have identified variants affecting…”
Get full text

A variant in FTO shows association with melanoma risk not due to BMI by Iles, Mark M, Law, Matthew H, Stacey, Simon N, Han, Jiali, Fang, Shenying, Pfeiffer, Ruth, Harland, Mark, Macgregor, Stuart, Taylor, John C, Aben, Katja K, Akslen, Lars A, Avril, Marie-Françoise, Azizi, Esther, Bakker, Bert, Benediktsdottir, Kristrun R, Bergman, Wilma, Scarrà, Giovanna Bianchi, Brown, Kevin M, Calista, Donato, Chaudru, Valérie, Fargnoli, Maria Concetta, Cust, Anne E, Demenais, Florence, de Waal, Anne C, Dębniak, Tadeusz, Elder, David E, Friedman, Eitan, Galan, Pilar, Ghiorzo, Paola, Gillanders, Elizabeth M, Goldstein, Alisa M, Gruis, Nelleke A, Hansson, Johan, Helsing, Per, Hočevar, Marko, Höiom, Veronica, Hopper, John L, Ingvar, Christian, Janssen, Marjolein, Jenkins, Mark A, Kanetsky, Peter A, Kiemeney, Lambertus A, Lang, Julie, Lathrop, G Mark, Leachman, Sancy, Lee, Jeffrey E, Lubiński, Jan, Mackie, Rona M, Mann, Graham J, Martin, Nicholas G, Mayordomo, Jose I, Molven, Anders, Mulder, Suzanne, Nagore, Eduardo, Novaković, Srdjan, Okamoto, Ichiro, Olafsson, Jon H, Olsson, Håkan, Pehamberger, Hubert, Peris, Ketty, Grasa, Maria Pilar, Planelles, Dolores, Puig, Susana, Puig-Butille, Joan Anton, Randerson-Moor, Juliette, Requena, Celia, Rivoltini, Licia, Rodolfo, Monica, Santinami, Mario, Sigurgeirsson, Bardur, Snowden, Helen, Song, Fengju, Sulem, Patrick, Thorisdottir, Kristin, Tuominen, Rainer, Van Belle, Patricia, van der Stoep, Nienke, van Rossum, Michelle M, Wei, Qingyi, Wendt, Judith, Zelenika, Diana, Zhang, Mingfeng, Landi, Maria Teresa, Thorleifsson, Gudmar, Bishop, D Timothy, Amos, Christopher I, Hayward, Nicholas K, Stefansson, Kari, Bishop, Julia A Newton, Barrett, Jennifer H

“…The GenoMEL consortium reports a genome-wide association study of melanoma based on imputation and identifies a variant in the FTO gene associated with…”
Get full text

Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits by Stefansson, Kari, Gudjonsson, Sigurjon A, Sigurdsson, Asgeir, Blondal, Thorarinn, Gilaberte, Yolanda, Botella-Estrada, Rafael, Saemundsdottir, Jona, Grasa, Matilde, Thorlacius, Theodora, Rudnai, Peter, Ragnarsson, Rafn, Mouy, Magali, Geller, Frank, Olafsson, Jon H, Stacey, Simon N, Benediktsdottir, Kristrun R, Thorlacius, Steinunn, Jonsson, Gudbjörn F, Mayordomo, José I, Gudbjartsson, Daniel F, Thorisdottir, Kristin, Helgason, Agnar, Nagore, Eduardo, Kumar, Rajiv, Gudmundsson, Julius, Thorsteinsdottir, Unnur, Rafnar, Thorunn, Bergthorsson, Jon T, Kristjansson, Kristleifur, Sigurgeirsson, Bardur, Juberías, Pablo, Gurzau, Eugene, Bjornsdottir, Gyda, Hansson, Johan, Thorleifsson, Gudmar, Kong, Augustine, Sulem, Patrick, Sveinsdottir, Steinunn G, Jakobsdottir, Margret, Carapeto, Francisco J, Jonasdottir, Aslaug, Koppova, Kvetoslava, Scherer, Dominique, Höiom, Veronica, Soriano, Virtudes, Tabuenca, Pilar

“…To search for new sequence variants that confer risk of cutaneous basal cell carcinoma (BCC), we conducted a genome-wide SNP association study of 930…”
Get full text

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer by Tabernero, J., Climent, M. A., Lluch, A., Albanell, J., Vermorken, J. B., Barnadas, A., Antón, A., Laurent, C., Mayordomo, J. I., Estaun, N., Losa, I., Guillem, V., Garcia-Conde, J., Tisaire, J. L., Baselga, J.

“…Background: A phase II randomised trial was conducted to evaluate the tolerability and activity of weekly or 3-weekly docetaxel in patients with metastatic…”
Get full text

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines by Zitvogel, L, Mayordomo, J I, Tjandrawan, T, DeLeo, A B, Clarke, M R, Lotze, M T, Storkus, W J

“…Antigen presentation by host dendritic cells (DC) is critical for the initiation of adaptive immune responses. We have previously demonstrated in immunogenic…”
Get full text

PBSC autotransplant for inflammatory bowel disease (IBD): a case of ulcerative colitis by Martí, J L, Mayordomo, J I, Isla, M D, Saenz, A, Escudero, P, Tres, A

Get full text

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity by Mayordomo, J.I, Zorina, T, Storkus, W.J, Zitvogel, L, Celluzzi, C, Falo, L.D, Melief, C.J, Ildstad, S.T, Martin Kast, W, Deleo, A.B, Lotze, M.T

“…Dendritic cells, the most potent 'professional' antigen-presenting cells, hold promise for improving the immunotherapy of cancer. In three different…”
Get full text

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity by Celluzzi, C M, Mayordomo, J I, Storkus, W J, Lotze, M T, Falo, Jr, L D

“…Cytotoxic T lymphocytes (CTLs) are a critical component of the immune response to tumors. Tumor-derived peptide antigens targeted by CTLs are being defined for…”
Get full text

Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized Trial by García-Carbonero, Rocio, Mayordomo, José I., Tornamira, María V., López-Brea, Marta, Rueda, Antonio, Guillem, Vicente, Arcediano, Alberto, Yubero, Alfonso, Ribera, Fernando, Gómez, Carlos, Trés, Alejandro, Pérez-Gracia, José L., Lumbreras, Carlos, Hornedo, Javier, Cortés-Funes, Hernan, Paz-Ares, Luis

“…Background: Granulocyte colony-stimulating factors (G-CSFs) have been shown to help prevent febrile neutropenia in certain subgroups of cancer patients…”
Get full text

Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial) by Ciruelos, E.M., Cortés, J., Cortés-Funes, H., Mayordomo, J.I., Bermejo, B., Ojeda, B., García, E., Rodríguez, C.A., Muñoz, M., Gómez, P., Manso, L., Andrés, R., Lluch, A., Saura, C., Mendiola, C., Baselga, J.

“…On the basis of clinical activity of capecitabine and gemcitabine for metastatic breast cancer, we carried out a multicenter phase II clinical trial on the…”
Get full text

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines by Mayordomo, J I, Loftus, D J, Sakamoto, H, De Cesare, C M, Appasamy, P M, Lotze, M T, Storkus, W J, Appella, E, DeLeo, A B

“…The BALB/c Meth A sarcoma carries a p53 missense mutation at codon 234, which occurs in a peptide, termed 234CM, capable of being presented to cytotoxic T…”
Get full text

Bone Marrow‐Derived Dendritic Cells Serve as Potent Adjuvants for Peptide‐Based Antitumor Vaccines by Mayordomo, Jose I., Zorina, Tatiana, Storkus, Walter J., Zitvogel, Laurence, Garcia‐Prats, Maria D., DeLeo, Albert B., Lotze, Michael T.

“…Dendritic cells (DCs) are considered the most effective antigen‐presenting cells (APCs) for primary immune responses. Since presentation of antigens to the…”
Get full text

PCN6 PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM IS COSTSAVING COMPARED WITH FILGRASTIM FOR BREAST CANCER IN SPAIN by Mayordomo, JI, Lopez Pousa, A, Arocho, R, Doan, QV, Dubois, RW, Liu, Z

Get full text

ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma (vol 40, pg 886, 2008) by Gudbjartsson, DF, Sulem, P, Stacey, SN, Goldstein, AM, Rafnar, T, Sigurgeirsson, B, Benediktsdottir, KR, Thorisdottir, K, Ragnarsson, R, Sveinsdottir, SG, Magnusson, V, Lindblom, A, Kostulas, K, Botella-Estrada, R, Soriano, V, Juberias, P, Grasa, M, Saez, B, Andres, R, Scherer, D, Rudnai, P, Gurzau, E, Koppova, K, Kiemeney, LA, Jakobsdottir, M, Steinberg, S, Helgason, A, Gretarsdottir, S, Tucker, MA, Mayordomo, JI, Nagore, E, Kumar, R, Hansson, J, Olafsson, JH, Gulcher, J, Kong, A, Thorsteinsdottir, U, Stefansson, K

Get full text

IL-12-engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo by Zitvogel, L, Couderc, B, Mayordomo, J I, Robbins, P D, Lotze, M T, Storkus, W J

“…The recent identification of tumor-associated antigens (TAA) and TAA-derived peptides presented by MHC molecules to T cells has provided the tools to design…”
Get more information

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors by Mayordomo, J I, Rivera, F, Díaz-Puente, M T, Lianes, P, Colomer, R, López-Brea, M, López, E, Paz-Ares, L, Hitt, R, García-Ribas, I

“…Several randomized trials have tested the use of granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in…”
Get more information

A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours by Garcia-Prats, M D, Ballestin, C, Sotelo, T, Lopez-Encuentra, A, Mayordomo, J I

“…Aims To determine the value of immunocytochemistry in differentiation of malignant pleural mesothelioma from carcinoma in a pleural biopsy using commercially…”
Get full text

Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: Preliminary results from a phase II trial by Pelegrı́, Amadeu, Calvo, Lourdes, Mayordomo, José I, Florián, Jesús, Vázquez, Santiago, Arcusa, Angels, Martı́n-Richard, Marta, Bayo, José L, Virizuela, Javier, Carrasco, Eva, Antón, Antonio

“…The purpose of this study was to assess the toxicity and efficacy of gemcitabine and docetaxel administered every other week as first-line therapy in…”
Get full text

Prognostic value of serum S-100B in malignant melanoma by Andrés, Raquel, Mayordomo, José I, Zaballos, Pedro, Rodino, Javier, Isla, Dolores, Escudero, Pilar, Elosegui, Luis, Filipovich, Elena, Saenz, Alberto, Polo, Eduardo, Tres, Alejandro

“…Although there is no established tumor marker of proven value for patients with melanoma, high serum levels of S-100B protein have been found in patients with…”
Get full text

Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer by Mayordomo, Jose Ignacio, Andres, Raquel, Isla, Maria Dolores, Murillo, Laura, Cajal, Rosana, Yubero, Alfonso, Blasco, Carmen, Lasierra, Pilar, Palomera, Luis, Fuertes, Miguel Angel, Güemes, Antonio, Sousa, Ramon, Garcia-Prats, Maria Dolores, Escudero, Pilar, Saenz, Alberto, Godino, Javier, Marco, Ivan, Saez, Berta, Visus, Carmen, Asin, Laura, Valdivia, Gabriel, Larrad, Luis, Tres, Alejandro

“…The purpose of the study was to test the immunological and clinical effects of infusions of dendritic cells pulsed with autologous tumor lysate in patients…”
Get full text